Publications

In recent years, enzyme-powered nanomotors (NMs) have emerged as promising tools for biomedical applications. They exhibit active motion in complex media, whereas traditional passive nanoparticles (NPs) typically remain trapped. Despite their potential, nanogels (NGs)-3D, cross-linked polymeric networks with high water retention and environmental responsiveness-remain underexplored as cores for enzymatic NMs. Here, fine-tuned NGs designed to confer smart properties are presented, allowing them to adapt their size and density in response to external stimuli (e.g., pH, temperature, and redox conditions). After anchoring urease to these NGs to produce nanogel-nanomotors (NGs-NMs), they exhibited both individual and collective motion at a very low urea concentration, enabling displacement in highly viscous environments. To achieve this, four NGs formulations based on p-(N-isopropylacrylamide) co-polymerized with p-Itaconic acid (p-(NIPAM-co-IAc)) are developed, cross-linked with either N,N '-methylenebisacrylamide (BIS) and/or N,N '-bis(acryloyl)cystamine (BAC), and coated with p-(2-hydroxyethyl methacrylate) (p-HEMA). This results, obtained via confocal microscopy and flow cytometry, demonstrate their rapid cell internalization. Moreover, synchrotron-based infrared spectroscopy (SR-FTIRM) allowed to demonstrate that NGs-NMs can tune the physicochemical composition of tumoral cells. This findings underscore the potential of NGs-NMs, combining adaptability, safety, and efficacy. They represent the evolution in NMs technology, paving the way for groundbreaking advancements in personalized medicine.

JTD Keywords: Active mater, Enzymatic nanomotors, Hydrogels, Nanobots, Nanogels, Poly(2-hydroxyethyl methacrylate), Ure, Viscous medi

© 2021 Wiley Periodicals LLC. Biohybrid robotics is a field in which biological entities are combined with artificial materials in order to obtain improved performance or features that are difficult to mimic with hand-made materials. Three main level of integration can be envisioned depending on the complexity of the biological entity, ranging from the nanoscale to the macroscale. At the nanoscale, enzymes that catalyze biocompatible reactions can be used as power sources for self-propelled nanoparticles of different geometries and compositions, obtaining rather interesting active matter systems that acquire importance in the biomedical field as drug delivery systems. At the microscale, single enzymes are substituted by complete cells, such as bacteria or spermatozoa, whose self-propelling capabilities can be used to transport cargo and can also be used as drug delivery systems, for in vitro fertilization practices or for biofilm removal. Finally, at the macroscale, the combinations of millions of cells forming tissues can be used to power biorobotic devices or bioactuators by using muscle cells. Both cardiac and skeletal muscle tissue have been part of remarkable examples of untethered biorobots that can crawl or swim due to the contractions of the tissue and current developments aim at the integration of several types of tissue to obtain more realistic biomimetic devices, which could lead to the next generation of hybrid robotics. Tethered bioactuators, however, result in excellent candidates for tissue models for drug screening purposes or the study of muscle myopathies due to their three-dimensional architecture. This article is categorized under: Therapeutic Approaches and Drug Discovery > Emerging Technologies Nanotechnology Approaches to Biology > Nanoscale Systems in Biology.

JTD Keywords: bacteria-bots, based biorobots, biorobots, bots, enzymatic nanomotors, hybrid robotics, muscle‐, Bacteria‐, Bacteria-bots, Biomimetic materials, Biorobots, Enzymatic nanomotors, Humans, Hybrid robotics, Muscle-based biorobots, Nanoparticles, Nanotechnology, Robotics

The low efficacy of current conventional treatments for bacterial infections increases mortality rates worldwide. To alleviate this global health problem, we propose drug-free enzyme-based nanomotors for the treatment of bacterial urinary-tract infections. We develop nanomotors consisting of mesoporous silica nanoparticles (MSNPs) that were functionalized with either urease (U-MSNPs), lysozyme (L-MSNPs), or urease and lysozyme (M-MSNPs), and use them against nonpathogenic planktonic Escherichia coli. U-MSNPs exhibited the highest bactericidal activity due to biocatalysis of urea into NaHCO3 and NH3, which also propels U-MSNPs. In addition, U-MSNPs in concentrations above 200 μg/mL were capable of successfully reducing 60% of the biofilm biomass of a uropathogenic E. coli strain. This study thus provides a proof-of-concept, demonstrating that enzyme-based nanomotors are capable of fighting infectious diseases. This approach could potentially be extended to other kinds of diseases by selecting appropriate biomolecules.

JTD Keywords: biofilms, carbonate, e. coli, enzymatic nanomotors, infections, lysozyme, micromotors, nanomachines, proteins, self-propulsion, Anti-bacterial agents, Biocatalysis, Biofilms, Canavalia, Drug carriers, E. coli, Eliminate escherichia-coli, Enzymatic nanomotors, Escherichia coli, Escherichia coli infections, Humans, Infections, Muramidase, Nanomachines, Nanoparticles, Self-propulsion, Silicon dioxide, Urease, Urinary tract infections